Epinecidin-1

General Information


DRACP ID  DRACP00457

Peptide Name   Epinecidin-1

Sequence  GFIFHIIKGLFHAGKMIHGLV

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Epinephelus nebulosus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma ~70% Cytotoxicity=25 mg/L MTS assay 6 h 1
HT-1080 Fibrosarcoma Sarcoma ~90% Cytotoxicity=25 mg/L MTS assay 6 h 1

Hemolytic Activity  EP-1 did not have a strong hemolytic effect at low doses

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00457

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C114H175N29O22S

Absent amino acids  CDENPQRSTWY

Common amino acids  GI

Mass  269283

Pl  10.81

Basic residues  5

Acidic residues  0

Hydrophobic residues  11

Net charge  5

Boman Index  2534

Hydrophobicity  109.05

Aliphatic Index  130

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23598079

Title  Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus

Doi 10.1016/j.peptides.2013.04.004

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.